Financial Markets Standards Board (FMSB) is pleased to announce that GSK has joined as a Corporate Member.
Myles McGuinness, CEO of Financial Markets Standards Board Limited said:
“We are delighted to welcome GSK as a Corporate Member of FMSB, reflecting the confidence placed in FMSB as an effective forum for developing Standards and Statements of Good Practice that are valued and used by an increasingly broad range of market participants. The participation of leading corporates such as GSK is vital to ensuring the balanced representation needed to fulfil our remit of supporting fair and effective markets. We look forward to drawing on their valuable perspective to take forward the ambitious workplan we have set out for 2026.”
Timothy Woodthorpe, Senior Vice President and Group Treasurer at GSK said:
“As a large corporate issuer, GSK is proud to join FMSB and support fair and effective markets for all stakeholders. FMSB membership means that we are at the heart of helping to develop respected, industry-led Standards and Statements of Good Practice. We look forward to working with fellow FMSB Members on the wide range of work they are engaged in.”
Notes to editors
About FMSB:
- Financial Markets Standards Board (FMSB) is an industry-led, member-funded global standards body for the wholesale financial markets.
- Created out of the Fair and Effective Markets Review (FEMR) in 2015, FMSB brings together its Members from banks, investment institutions, infrastructure and information providers, corporates, pension funds and non-bank liquidity providers, to develop Standards, Statements of Good Practice and Spotlight Reviews that raise standards of behaviour, competence and awareness – to promote the fairness and effectiveness of global wholesale financial markets.
- As well as standard setting, subject matter experts from member firms debate issues in working groups and are able to benchmark their approaches against industry peers, thus helping to lift standards of conduct.
- FMSB’s full membership list is here
About GSK:
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.
For more information:
Laura Conaghan
+44 (0)203 961 6150
Laura.conaghan@fmsb.com